Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Pharmazie in Unserer Zeit
|
July 4, 2012
[Editorial: Pharmazie in unserer Zeit 4/2012]
Theo Dingermann, Manfred Schubert-Zsilavecz, Martin Schulz
Oncogene
|
June 6, 2003
MLL-mediated transcriptional gene regulation investigated by gene expression profiling
Dorothe Schraets, Tanja Lehmann, Theo Dingermann, et al.
Pharmazie in Unserer Zeit
|
August 30, 2008
[Statement from the DPhG: DPhG opinion on the proposed health claims regulation]
Susanne Alban, Theo Dingermann, Henning Blume, et al.
Biotechnology Journal
|
October 22, 2009
Statistical aspects of design and validation of microtitre-plate-based linear and non-linear parallel in vitro bioassays
Hanne Zimmermann, Daniel Gerhard, Theo Dingermann, et al.
Nucleic Acids Research
|
April 30, 2010
Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells
Irina Eberle, Birgit Pless, Miriam Braun, et al.
Protein Expression and Purification
|
May 10, 2006
Overexpression, refolding, and purification of polyhistidine-tagged human retinoic acid related orphan receptor RORalpha4
Adriane Lechtken, Ilse Zündorf, Theo Dingermann, et al.
American Journal of Blood Research
|
March 21, 2012
Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancer
Eric Kowarz, Jennifer Merkens, Michael Karas, et al.
Pharmazie in Unserer Zeit
|
February 23, 2008
[Inside out--the distinguishing characteristics of the stressed cell]
Thomas Grode, Martina Kec, Milena Madry, et al.
Oncogene
|
June 29, 2004
Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?
Adelheid Bursen, Sven Moritz, Anne Gaussmann, et al.
Pharmazie in Unserer Zeit
|
August 30, 2008
[Don't stop me now!]
Andrea Wolf, Jennifer Schaack, Louise Freikamp, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Pharmazie in Unserer Zeit
|
July 4, 2012
[Editorial: Pharmazie in unserer Zeit 4/2012]
Theo Dingermann, Manfred Schubert-Zsilavecz, Martin Schulz
Oncogene
|
June 6, 2003
MLL-mediated transcriptional gene regulation investigated by gene expression profiling
Dorothe Schraets, Tanja Lehmann, Theo Dingermann, et al.
Pharmazie in Unserer Zeit
|
August 30, 2008
[Statement from the DPhG: DPhG opinion on the proposed health claims regulation]
Susanne Alban, Theo Dingermann, Henning Blume, et al.
Biotechnology Journal
|
October 22, 2009
Statistical aspects of design and validation of microtitre-plate-based linear and non-linear parallel in vitro bioassays
Hanne Zimmermann, Daniel Gerhard, Theo Dingermann, et al.
Nucleic Acids Research
|
April 30, 2010
Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells
Irina Eberle, Birgit Pless, Miriam Braun, et al.
Protein Expression and Purification
|
May 10, 2006
Overexpression, refolding, and purification of polyhistidine-tagged human retinoic acid related orphan receptor RORalpha4
Adriane Lechtken, Ilse Zündorf, Theo Dingermann, et al.
American Journal of Blood Research
|
March 21, 2012
Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancer
Eric Kowarz, Jennifer Merkens, Michael Karas, et al.
Pharmazie in Unserer Zeit
|
February 23, 2008
[Inside out--the distinguishing characteristics of the stressed cell]
Thomas Grode, Martina Kec, Milena Madry, et al.
Oncogene
|
June 29, 2004
Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?
Adelheid Bursen, Sven Moritz, Anne Gaussmann, et al.
Pharmazie in Unserer Zeit
|
August 30, 2008
[Don't stop me now!]
Andrea Wolf, Jennifer Schaack, Louise Freikamp, et al.
Page
of 9